Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Economic Competition"" wg kryterium: Temat


Tytuł :
Strategies to Overcome the Market Dominance of Hospitals-Reply.
Autorzy :
Shah S; Stanford University School of Medicine, Stanford, California.
Navathe AS; Department of Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Kocher RP; Stanford University School of Medicine, Stanford, California.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Jul 20; Vol. 326 (3), pp. 278-279.
Typ publikacji :
Letter; Comment
MeSH Terms :
Economic Competition*
Hospitals*
Opinia redakcyjna
Tytuł :
Applicability of European Union Competition Law to Health Care Providers: The Dividing Line between Economic and Noneconomic Activities.
Autorzy :
Nikolić B; University of Ljubljana.
Pokaż więcej
Źródło :
Journal of health politics, policy and law [J Health Polit Policy Law] 2021 Feb 01; Vol. 46 (1), pp. 49-70.
Typ publikacji :
Journal Article
MeSH Terms :
European Union*
Delivery of Health Care/*economics
Delivery of Health Care/*legislation & jurisprudence
Economic Competition/*economics
Economic Competition/*legislation & jurisprudence
Health Personnel/*economics
Health Personnel/*legislation & jurisprudence
Delivery of Health Care/organization & administration ; Economic Competition/organization & administration ; Guidelines as Topic ; Health Personnel/organization & administration ; Humans ; Private Sector ; Public Sector
Czasopismo naukowe
Tytuł :
Private Equity and Physician Medical Practices - Navigating a Changing Ecosystem.
Autorzy :
Zhu JM; From the Division of General Internal Medicine, Oregon Health and Science University, Portland (J.M.Z.); and the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, the Johns Hopkins Carey Business School, and the Hopkins Business of Health Initiative, Johns Hopkins University, Baltimore (D.P.).
Polsky D; From the Division of General Internal Medicine, Oregon Health and Science University, Portland (J.M.Z.); and the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, the Johns Hopkins Carey Business School, and the Hopkins Business of Health Initiative, Johns Hopkins University, Baltimore (D.P.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Mar 18; Vol. 384 (11), pp. 981-983. Date of Electronic Publication: 2021 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Economic Competition*
Government Regulation*
Ownership*
Private Sector/*legislation & jurisprudence
Professional Practice/*organization & administration
Group Practice/organization & administration ; Hospital-Physician Joint Ventures ; Physicians/organization & administration ; Practice Management/legislation & jurisprudence ; Practice Management/organization & administration ; Professional Practice/economics ; Professional Practice/legislation & jurisprudence ; State Government ; United States
Czasopismo naukowe
Tytuł :
Federal Spending on Off-Patent Drugs That Lack Generic Competition.
Autorzy :
Rome BN; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. .; Harvard Medical School, Boston, MA, USA. .
Kesselheim AS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Journal of general internal medicine [J Gen Intern Med] 2021 Mar; Vol. 36 (3), pp. 821-823. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drugs, Generic*
Economic Competition*
Drug Costs ; Drug Industry ; Humans ; United States
Czasopismo naukowe
Tytuł :
Untangling the complexity of market competition in consumer goods-A complex Hilbert PCA analysis.
Autorzy :
Mizuno M; School of Commerce, Meiji University, Tokyo, Japan.
Aoyama H; Research Institute of Economy, Trade and Industry, Tokyo, Japan.; RIKEN iTHEMS, Wako, Saitama, Japan.
Fujiwara Y; Graduate School of Simulation Studies, University of Hyogo, Kobe, Japan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Feb 03; Vol. 16 (2), pp. e0245531. Date of Electronic Publication: 2021 Feb 03 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Consumer Behavior*
Economic Competition*
Marketing*
Beer/*economics
Humans ; Japan
Czasopismo naukowe
Tytuł :
Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians.
Autorzy :
Daniel H; American College of Physicians, Washington, DC (H.D., J.S.).
Serchen J; American College of Physicians, Washington, DC (H.D., J.S.).
Cooney TG; Oregon Health & Science University, Portland, Oregon (T.G.C.).
Pokaż więcej
Corporate Authors :
Health and Public Policy Committee of the American College of Physicians
Źródło :
Annals of internal medicine [Ann Intern Med] 2020 Dec 15; Vol. 173 (12), pp. 1002-1003. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :
Journal Article
MeSH Terms :
Economic Competition*
Health Policy*/economics
Prescription Drugs/*economics
Biosimilar Pharmaceuticals/economics ; Biosimilar Pharmaceuticals/therapeutic use ; Drug Industry/economics ; Humans ; Organizational Policy ; Orphan Drug Production/economics ; Orphan Drug Production/legislation & jurisprudence ; Prescription Drugs/therapeutic use ; Societies, Medical ; United States
Czasopismo naukowe
Tytuł :
Impact of Environmental Regulation on Scientific and Technological Competitiveness of Resource-Based Cities in China-Based on Panel Data of 33 Resource-Based Cities.
Autorzy :
Zhang X; College of Economics and Management, Northwest A&F University, Yangling 712100, China.
Qu M; College of Economics and Management, Northwest A&F University, Yangling 712100, China.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Dec 09; Vol. 17 (24). Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Economic Competition*/statistics & numerical data
Environmental Pollution*/legislation & jurisprudence
Industry*/economics
Industry*/legislation & jurisprudence
Technology*/economics
Technology*/legislation & jurisprudence
China ; Cities ; Government Regulation
Czasopismo naukowe
Tytuł :
Generic Competition for Drugs Treating Rare Diseases.
Autorzy :
Beall RF; Reed F. Beall, Ph.D., is an assistant professor in health care policy in the Department of Community Health Sciences at the Cumming School of Medicine and at the O'Brien Institute for Public Health at the University of Calgary. Amity E. Quinn, Ph.D., is a post-doctoral fellow in health economics in the Department of Community Health Sciences at the at the University of Calgary. Aaron S. Kesselheim, M.D., J.D, M.P.H., is a professor of medicine and director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital and Harvard Medical School. At the time of the study, Frazer A. Tessema, B.A., was a research assistant with PORTAL at Brigham and Women's Hospital and Harvard Medical School. Ameet Sarpatwari, Ph.D., J.D., is an assistant professor of medicine and assistant director of PORTAL at Brigham and Women's Hospital and Harvard Medical School.
Quinn AE; Reed F. Beall, Ph.D., is an assistant professor in health care policy in the Department of Community Health Sciences at the Cumming School of Medicine and at the O'Brien Institute for Public Health at the University of Calgary. Amity E. Quinn, Ph.D., is a post-doctoral fellow in health economics in the Department of Community Health Sciences at the at the University of Calgary. Aaron S. Kesselheim, M.D., J.D, M.P.H., is a professor of medicine and director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital and Harvard Medical School. At the time of the study, Frazer A. Tessema, B.A., was a research assistant with PORTAL at Brigham and Women's Hospital and Harvard Medical School. Ameet Sarpatwari, Ph.D., J.D., is an assistant professor of medicine and assistant director of PORTAL at Brigham and Women's Hospital and Harvard Medical School.
Kesselheim AS; Reed F. Beall, Ph.D., is an assistant professor in health care policy in the Department of Community Health Sciences at the Cumming School of Medicine and at the O'Brien Institute for Public Health at the University of Calgary. Amity E. Quinn, Ph.D., is a post-doctoral fellow in health economics in the Department of Community Health Sciences at the at the University of Calgary. Aaron S. Kesselheim, M.D., J.D, M.P.H., is a professor of medicine and director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital and Harvard Medical School. At the time of the study, Frazer A. Tessema, B.A., was a research assistant with PORTAL at Brigham and Women's Hospital and Harvard Medical School. Ameet Sarpatwari, Ph.D., J.D., is an assistant professor of medicine and assistant director of PORTAL at Brigham and Women's Hospital and Harvard Medical School.
Tessema FA; Reed F. Beall, Ph.D., is an assistant professor in health care policy in the Department of Community Health Sciences at the Cumming School of Medicine and at the O'Brien Institute for Public Health at the University of Calgary. Amity E. Quinn, Ph.D., is a post-doctoral fellow in health economics in the Department of Community Health Sciences at the at the University of Calgary. Aaron S. Kesselheim, M.D., J.D, M.P.H., is a professor of medicine and director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital and Harvard Medical School. At the time of the study, Frazer A. Tessema, B.A., was a research assistant with PORTAL at Brigham and Women's Hospital and Harvard Medical School. Ameet Sarpatwari, Ph.D., J.D., is an assistant professor of medicine and assistant director of PORTAL at Brigham and Women's Hospital and Harvard Medical School.
Sarpatwari A; Reed F. Beall, Ph.D., is an assistant professor in health care policy in the Department of Community Health Sciences at the Cumming School of Medicine and at the O'Brien Institute for Public Health at the University of Calgary. Amity E. Quinn, Ph.D., is a post-doctoral fellow in health economics in the Department of Community Health Sciences at the at the University of Calgary. Aaron S. Kesselheim, M.D., J.D, M.P.H., is a professor of medicine and director of the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital and Harvard Medical School. At the time of the study, Frazer A. Tessema, B.A., was a research assistant with PORTAL at Brigham and Women's Hospital and Harvard Medical School. Ameet Sarpatwari, Ph.D., J.D., is an assistant professor of medicine and assistant director of PORTAL at Brigham and Women's Hospital and Harvard Medical School.
Pokaż więcej
Źródło :
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2020 Dec; Vol. 48 (4), pp. 789-795.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Economic Competition*
Drugs, Generic/*economics
Orphan Drug Production/*economics
Rare Diseases/*drug therapy
Humans
Czasopismo naukowe
Tytuł :
Comparing Onset of Biosimilar Versus Generic Competition in the United States.
Autorzy :
Beall RF; Department of Community Health Sciences, O'Brien Institute of Public Health, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ronksley PE; Department of Community Health Sciences, O'Brien Institute of Public Health, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Wick J; Department of Community Health Sciences, O'Brien Institute of Public Health, Cummings School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Darrow JJ; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Sarpatwari A; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kesselheim AS; Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Dec; Vol. 108 (6), pp. 1308-1314. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Approval*
Drug Costs*
Economic Competition*
Economics, Pharmaceutical*
United States Food and Drug Administration*
Biosimilar Pharmaceuticals/*economics
Drugs, Generic/*economics
Biosimilar Pharmaceuticals/therapeutic use ; Cost Savings ; Drugs, Generic/therapeutic use ; Health Expenditures ; Humans ; Patents as Topic ; Time Factors ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies